Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ warning ...

The BIO campaign warns that decreased funding could hamper both current patient care and the future pipeline of medical breakthroughs. By featuring documentary-style stories of researchers and ...

Many cell therapy outfits have struggled this year, with numerous companies resorting to downsizing or shutting down entirely. (iStock / Getty Images Plus) One of the top fundraisers of 2024 is ...

Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems ...

The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European biopharma market.

The majority of Americans do not live in a biotech hub. Yet 62 percent of all U.S. biopharma venture investment occurs in Massachusetts and California, according to Pitchbook, while 77 percent of ...

This new book by the National Research Council recommends that the government expand existing regulations and rely on self-governance by scientists rather than adopt intrusive new policies. One key ...

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...

Biotech Labz Supply has announced an exciting expansion of its product line, focusing on research peptides that are gaining attention in the scientific community. As a leading supplier of high-quality ...